Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Receivables (2024 - 2025)

Korro Bio (KRRO) has disclosed Change in Receivables for 2 consecutive years, with -$269000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$269000.0, compared with a TTM value of $820000.0 through Sep 2025, changed N/A, and an annual FY2024 reading of $1.7 million, changed N/A over the prior year.
  • Change in Receivables was -$269000.0 for Q3 2025 at Korro Bio, up from -$835000.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $1.7 million in Q4 2024 and bottomed at -$835000.0 in Q2 2025.